Does TOCILIZUMAB Cause Injection site hypersensitivity? 103 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 103 reports of Injection site hypersensitivity have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 0.1% of all adverse event reports for TOCILIZUMAB.
103
Reports of Injection site hypersensitivity with TOCILIZUMAB
0.1%
of all TOCILIZUMAB reports
1
Deaths
23
Hospitalizations
How Dangerous Is Injection site hypersensitivity From TOCILIZUMAB?
Of the 103 reports, 1 (1.0%) resulted in death, 23 (22.3%) required hospitalization.
Is Injection site hypersensitivity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 103 reports have been filed with the FAERS database.
What Other Side Effects Does TOCILIZUMAB Cause?
Drug ineffective (32,342)
Rheumatoid arthritis (20,652)
Pain (18,384)
Off label use (18,256)
Arthralgia (15,536)
Joint swelling (14,831)
Fatigue (13,802)
Rash (12,327)
Drug intolerance (11,952)
Contraindicated product administered (11,547)
What Other Drugs Cause Injection site hypersensitivity?
ETANERCEPT (363)
TIRZEPATIDE (333)
ADALIMUMAB (295)
DUPILUMAB (125)
METHOTREXATE (82)
DULAGLUTIDE (73)
IXEKIZUMAB (71)
OCTREOTIDE (67)
ANAKINRA (60)
GLATIRAMER (60)
Which TOCILIZUMAB Alternatives Have Lower Injection site hypersensitivity Risk?
TOCILIZUMAB vs TOCILIZUMAB-AAZG
TOCILIZUMAB vs TOCOPHEROL
TOCILIZUMAB vs TOFACITINIB
TOCILIZUMAB vs TOFERSEN
TOCILIZUMAB vs TOLNAFTATE